Seres Therapeutics, PTC Therapeutics and Inovio Pharmaceuticals were among the biotech stock movers in premarket trading on Thursday.
The firms all have drugs they want the feds to bend the rules to approve.
Nine biotech and drug companies want FDA approval, but need changed standards to get it.
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.